Skye Bioscience, Inc. — Director's Dealing 2015

Aug 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-08-20

Reporting Person: McLaughlin Gerald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-20	Common Stock	C	31250	—	Acquired	31250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-20	Series A Preferred Stock	$	C	10000	Disposed		Common Stock (31250)	Direct

Footnotes

F1: Shares of Series A Preferred Stock automatically converted into Common Stock on a 3.125-for-1 basis without payment of further consideration upon the closing of the Issuer's private offering on August 20, 2015, as reported in the Issuer's Form 8-K filed on August 21, 2015.